NIH-funded research R01 grant

AI-Enhanced Virtual Reality CBT to Reduce Anxiety for IBD Patients

Official title: AI-Enhanced Virtual Reality Cognitive Behavioral Therapy to Reduce Anxiety and Improve Quality of Life in Patients with Inflammatory Bowel Disease: A Multicenter Pilot and Feasibility Study

Funded at Cedars-Sinai Medical Center · NIH-11415875 · Data updated 2026-11-12

A home-based VR and AI-powered cognitive behavioral therapy program is being tested to help people with inflammatory bowel disease feel less anxious and improve their quality of life.

More Anxiety research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startSeptember 9, 2025
Project endJune 30, 2028
Funding year2026
Award (this year)$332,410
NIH project number5R01DK144719-02
Project IDNIH-11415875 on NIH RePORTER

Who could benefit from this research

Could help

Adults with inflammatory bowel disease and clinically significant anxiety, who have access to home VR technology.

Less likely to help

Individuals without anxiety or without access to the required home VR setup may not benefit.

What this research studies

This project will test an 8-week, home-based VR/AI CBT program against a sham VR control in adults with inflammatory bowel disease who also have anxiety. Participants will use a self-guided, immersive therapy delivered through virtual reality, with AI components to tailor the experience, across two major U.S. centers. The study is a pilot randomized controlled trial designed to assess feasibility and preliminary clinical impact on anxiety, health-related quality of life, and potentially inflammatory biomarkers. If feasible and beneficial, the approach could offer scalable, accessible mental health support for IBD patients, including those in rural or underserved areas. The study follows an established behavioral treatment development framework (ORBIT) to move from development to pilot testing.

Why it matters

Potential benefit: If successful, patients with IBD and anxiety could have a scalable, home-based therapy option to improve mood and quality of life.

How similar studies have gone: Previous work in VR-based therapies for anxiety shows promise, and this study builds on that with AI-enhancement in a specific patient group.

Where this research is happening

  • Cedars-Sinai Medical Center
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Spiegel, Brennan — Cedars-Sinai Medical Center
  • Study coordinator: Spiegel, Brennan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.